StonvexLoading…
StonvexStonvexStonvexCore line items from KELYA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-29 | Annual 2025 2025-12-28 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 |
|---|---|---|---|---|---|
Revenue | $1.04B | $1.04B | $4.25B | $3.20B | $2.27B |
Operating Income | Not available | $-5.10M | $-69.80M | $-69.10M | $33.00M |
Net Income | Not available | $-5.90M | $-254.10M | $-125.30M | $24.80M |
EPS (Diluted) | $0.24 | $-0.17 | $-7.24 | $-3.56 | $0.67 |
Total Assets | Not available | $2.25B | $2.25B | $2.39B | $2.51B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $25.60M | $33.00M | $30.10M | $18.00M |
Free Cash Flow OCF − CapEx | Not available | $-26.50M | $114.10M | $87.20M | $114.80M |
Shares Outstanding | Not available | 34.40M | 35.10M | 35.20M | 35.60M |